Infectious Disease and Microbiome

Screens of the Ó³»­´«Ã½â€™s entire DOS (Diversity Oriented Synthesis) library of over 100,000 small molecules on the malaria parasite P. falciparum have identified compounds that act on a novel malaria target during all three stages of the disease.

After screening a library of over 100,000 small molecules, researchers from the Ó³»­´«Ã½ of MIT and Harvard have identified compounds that act on a novel target in the malaria parasite, Plasmodium falciparum. resulted in the publication of a paper (available online September 7 inNature] and an open, data-rich resource for the malaria research community called the(MTRP).

Ó³»­´«Ã½ Press releases and news stories

Getting smart about antibiotics
Ó³»­´«Ã½ institute member James Collins demystifies how antibiotics work, laying a path toward smarter, more effective use of existing bacteria-fighting drugs

Resisting resistance in TB
Antibiotics do patients no good if the pathogen being targeted is resistant to them. When it comes to tuberculosis, avoiding treatments destined to fail can be lifesaving.